ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,842Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 2094

$1.19M Total Retail Price of All Prescriptions

Rank: 54 out of 2094

718 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 718 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 718 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 13,410 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 541 499 1 2
LEVOTHYROXINE SODIUM 504 483 2 3
SIMVASTATIN 469 454 3 1
LISINOPRIL 434 418 4 7
FUROSEMIDE 398 371 5 6
METOPROLOL SUCCINATE 370 348 6 9
WARFARIN SODIUM 316 280 7 11
METOPROLOL TARTRATE 309 298 8 10
HYDROCODONE-ACETAMINOPHEN 305 222 S3 9 42
DONEPEZIL HCL 262 255 10 20
ATORVASTATIN CALCIUM 249 241 11 5
OXYCODONE-ACETAMINOPHEN 240 205 S2 12 40
NAMENDA 240 237 12 32
OMEPRAZOLE 234 219 14 4
METFORMIN HCL 219 196 15 8
SERTRALINE HCL 204 172 16 26
CARVEDILOL 183 168 17 19
GABAPENTIN 171 131 18 23
CLOPIDOGREL 164 160 19 22
DIGOXIN 163 159 20 51
FAMOTIDINE 160 158 21 34
CRESTOR 156 135 22 15
NOVOLOG FLEXPEN 148 147 23 142
FENTANYL 145 141 S2 24 68
LANTUS 133 121 25 66
ESCITALOPRAM OXALATE 126 117 26 46
PLAVIX 123 121 27 38
ALENDRONATE SODIUM 121 121 28 30
HYDRALAZINE HCL 120 111 29 89
ISOSORBIDE MONONITRATE ER 112 112 30 57
LEVEMIR FLEXPEN 110 110 31 188
HYDROCHLOROTHIAZIDE 108 106 32 12
LOSARTAN POTASSIUM 108 108 32 17
CITALOPRAM HBR 105 86 34 47
LANTUS SOLOSTAR 100 99 35 76
AZITHROMYCIN 98 83 36 27
DIOVAN 94 82 37 13
RAMIPRIL 93 82 38 48
PRANDIN 90 78 39 125
NEXIUM 90 81 39 16
MIRTAZAPINE 86 80 41 43
GLYBURIDE 84 84 R 42 95
LEVOFLOXACIN 84 79 42 70
RISPERIDONE 81 80 44 56
LIPITOR 80 76 45 39
ADVAIR DISKUS 79 65 46 36
NOVOFINE AUTOCOVER 79 79 46 289
TAMSULOSIN HCL 79 64 46 29
ATENOLOL 78 67 49 21
BETAMETHASONE DIPROPIONATE 78 65 49 202
ZOLPIDEM TARTRATE 75 67 51 14
CARBIDOPA-LEVODOPA 73 73 52 102
CIPROFLOXACIN HCL 71 57 53 81
FLUOXETINE HCL 71 63 53 139
QUETIAPINE FUMARATE 70 52 55 71
DILTIAZEM 24HR CD 70 70 55 110
PROAIR HFA 68 47 57 45
LEVETIRACETAM 66 62 58 78
POTASSIUM CHLORIDE 65 61 59 24
PANTOPRAZOLE SODIUM 65 48 59 37
TRAMADOL HCL 65 59 59 33
CEFUROXIME 63 50 62 137
LIDODERM 63 60 62 59
PRAVASTATIN SODIUM 62 53 64 18
CYMBALTA 62 61 64 61
OXYCODONE HCL-ACETAMINOPHEN 62 49 S2 64 119
JANUVIA 61 61 67 35
ENALAPRIL MALEATE 60 59 68 25
ARANESP 56 56 69 330
CLONIDINE HCL 55 47 70 62
AMOXICILLIN 54 44 71 147
FINASTERIDE 54 54 71 97
CELEBREX 53 51 73 74
TRICOR 53 46 73 99
IPRATROPIUM-ALBUTEROL 52 49 75 92
PAROXETINE HCL 52 51 75 77
IBUPROFEN 52 28 75 73
LATANOPROST 52 52 75 153
PHENYTOIN SODIUM EXTENDED 51 32 79 158
ALPRAZOLAM 51 34 79 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.